AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Hims & Hers Health ( HIMS, Financials) shares slumped 24.5% on Thursday as Amazon ( AMZN, Financials) expanded into hair loss ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy.

Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel ...

Health-care companies fell sharply after reports that Donald Trump will pick Robert F. Kennedy Jr. as his nominee for head of Health and Human Services Department.

Detailed price information for Walt Disney Company (DIS-N) from The Globe and Mail including charting and trades.

Amazon’s partnership allows TikTok users to purchase products from the shopping site without leaving the Chinese-owned social ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Amazon announced a new move in the pharmacy sector, introducing low-cost treatments for lifestyle conditions like hair loss ...

Shares of Hims & Hers (HIMS) are sliding on Thursday after Amazon (AMZN) announced the launch of its Amazon One Medical Pay-per-visit ...

Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment ...